Adenosine A2A and Beta-2 Adrenergic Receptor Agonists: Novel Selective and Synergistic Multiple Myeloma Targets Discovered through Systematic Combination ScreeningRichard J. Rickles, Margaret Lee, Constantine S. Mitsiades et al.|Molecular Cancer Therapeutics|2012Cited by 19
Data from Adenosine A2A and Beta-2 Adrenergic Receptor Agonists: Novel Selective and Synergistic Multiple Myeloma Targets Discovered through Systematic Combination ScreeningRichard J. Rickles, Margaret Lee, Winnie F. Tam et al.|Unknown|2023Cited by 0
Supplementary Figures 1 - 10 from Adenosine A2A and Beta-2 Adrenergic Receptor Agonists: Novel Selective and Synergistic Multiple Myeloma Targets Discovered through Systematic Combination ScreeningRichard J. Rickles, Margaret Lee, Winnie F. Tam et al.|Unknown|2023Cited by 0
Supplementary Figure Legend from Adenosine A2A and Beta-2 Adrenergic Receptor Agonists: Novel Selective and Synergistic Multiple Myeloma Targets Discovered through Systematic Combination ScreeningRichard J. Rickles, Margaret Lee, Winnie F. Tam et al.|Unknown|2023Cited by 0
Supplementary Figure Legend from Adenosine A2A and Beta-2 Adrenergic Receptor Agonists: Novel Selective and Synergistic Multiple Myeloma Targets Discovered through Systematic Combination ScreeningRichard J. Rickles, Margaret Lee, Winnie F. Tam et al.|Unknown|2023Cited by 0